CXCL10 and central nervous system cancer: We first constructed the fusion gene IP10-scFv that specifically recognized glioma-specific EGFRvIII antigen, which is commonly expressed on the membrane surface of glioma cells, and effectively recruited glioma-specific CTLs into the tumor to inhibit tumor growth in mice [27].